Protective Effects of Human Pericyte-like Adipose-Derived Mesenchymal Stem Cells on Human Retinal Endothelial Cells in an In Vitro Model of Diabetic Retinopathy: Evidence for Autologous Cell Therapy DOI Open Access
Gabriella Lupo, Aleksandra Agafonova,

Alessia Cosentino

и другие.

International Journal of Molecular Sciences, Год журнала: 2023, Номер 24(2), С. 913 - 913

Опубликована: Янв. 4, 2023

Diabetic retinopathy (DR) is characterized by morphologic and metabolic alterations in endothelial cells (ECs) pericytes (PCs) of the blood–retinal barrier (BRB). The loss interendothelial junctions, increased vascular permeability, microaneurysms, finally, EC detachment are main features DR. In this scenario, a pivotal role played extensive PCs. Based on previous results, aim study was to assess possible beneficial effects exerted adipose mesenchymal stem (ASCs) their pericyte-like differentiated phenotype (P-ASCs) human retinal (HRECs) high glucose conditions (25 mM glucose, HG). P-ASCs were more able preserve BRB integrity than ASCs terms (a) transendothelial electrical resistance (TEER); (b) expression adherens junction tight proteins (VE-cadherin ZO-1); (c) reduction mRNA levels inflammatory cytokines TNF-α, IL-1β, MMP-9; (d) angiogenic factor VEGF fibrotic TGF-β1. Moreover, counteracted HG-induced activation pro-inflammatory phospho-ERK1/2/phospho-cPLA2/COX-2 pathway. Finally, crosstalk between HRECs or based PDGF-B/PDGFR-β axis at level described herein. Thus, might be considered valuable candidates for therapeutic approaches aimed countering disruption

Язык: Английский

Pathophysiological communication between hepatocytes and non-parenchymal cells in liver injury from NAFLD to liver fibrosis DOI
Santosh Kumar,

Qihua Duan,

Rongxue Wu

и другие.

Advanced Drug Delivery Reviews, Год журнала: 2021, Номер 176, С. 113869 - 113869

Опубликована: Июль 16, 2021

Язык: Английский

Процитировано

232

Pathophysiology and Treatment of Diabetic Cardiomyopathy and Heart Failure in Patients with Diabetes Mellitus DOI Open Access
Kazufumi Nakamura, Toru Miyoshi, Masashi Yoshida

и другие.

International Journal of Molecular Sciences, Год журнала: 2022, Номер 23(7), С. 3587 - 3587

Опубликована: Март 25, 2022

There is a close relationship between diabetes mellitus and heart failure, an independent risk factor for failure. Diabetes failure are linked by not only the complication of ischemic disease, but also metabolic disorders such as glucose toxicity lipotoxicity based on insulin resistance. Cardiac dysfunction in absence coronary artery hypertension, valvular disease called diabetic cardiomyopathy. Diabetes-induced hyperglycemia hyperinsulinemia lead to capillary damage, myocardial fibrosis, hypertrophy with mitochondrial dysfunction. Lipotoxicity extensive fat deposits or lipid droplets observed cardiomyocytes. Furthermore, increased oxidative stress inflammation cause cardiac fibrosis hypertrophy. Treatment sodium cotransporter 2 (SGLT2) inhibitor currently one most effective treatments associated diabetes. However, treatment myocardium has yet been established, establishment needed future. This review provides overview patients clinical practice clinicians.

Язык: Английский

Процитировано

158

Heart failure in diabetes DOI
Stanislovas S. Jankauskas, Urna Kansakar, Fahimeh Varzideh

и другие.

Metabolism, Год журнала: 2021, Номер 125, С. 154910 - 154910

Опубликована: Окт. 8, 2021

Язык: Английский

Процитировано

141

Inter-organ crosstalk during development and progression of type 2 diabetes mellitus DOI Open Access
Georgia Xourafa,

Melis Korbmacher,

Michael Roden

и другие.

Nature Reviews Endocrinology, Год журнала: 2023, Номер 20(1), С. 27 - 49

Опубликована: Окт. 16, 2023

Язык: Английский

Процитировано

101

Fibroblasts: Immunomodulatory factors in refractory diabetic wound healing DOI Creative Commons

Ye Liu,

Yiqiu Liu, Wenjie He

и другие.

Frontiers in Immunology, Год журнала: 2022, Номер 13

Опубликована: Авг. 5, 2022

Diabetes is a systemic disease in which patients with diabetes may develop peripheral neuropathy of the lower extremities and vascular due to long-term continuous exposure high glucose. Delayed wound healing one major complications diabetes. Slow diabetic associated glucose toxicity. When condition deteriorates, patient needs be amputated, seriously affects quality life even endangers patient. In general, delayed lack chemokines, abnormal inflammatory response, angiogenesis epithelial formation, fibroblast dysfunction. The incidence several chronic debilitating conditions increasing diabetes, such as renal insufficiency, heart failure, hepatic insufficiency. Fibrosis an inappropriate deposition extracellular matrix (ECM) proteins. It common causing organ fibrotic mechanism fibroblasts involve direct activation permanent fibroblasts. also degeneration fibers after hyperglycemia stimulates immune cells, or organ-specific parenchymal cells. Numerous studies confirm that play essential role treating its complications. primary function construct reshape ECM. Nowadays, widespread use single-cell RNA sequencing (scRNA-seq), number have found become critical sentinel can detect not only regulation response but molecular pattern related injury. By exploring heterogeneity functional changes manuscript discusses used immunomodulatory factors refractory healing, providing new ideas for treatment healing.

Язык: Английский

Процитировано

100

Extracellular Matrix Remodeling in Vascular Disease: Defining Its Regulators and Pathological Influence DOI Open Access
Prisca K. Lin, George E. Davis

Arteriosclerosis Thrombosis and Vascular Biology, Год журнала: 2023, Номер 43(9), С. 1599 - 1616

Опубликована: Июль 6, 2023

Because of structural and cellular differences (ie, degrees matrix abundance cross-linking, mural cell density, adventitia), large medium-sized vessels, in comparison to capillaries, react a unique manner stimuli that induce vascular disease. A stereotypical injury response is ECM (extracellular matrix) remodeling occurs particularly larger vessels injurious stimuli, such as elevated angiotensin II, hyperlipidemia, hyperglycemia, genetic deficiencies, inflammatory infiltration, or exposure proinflammatory mediators. Even with substantial prolonged damage, large- arteries, persist, but become modified by (1) changes wall cellularity; (2) modifications the differentiation status endothelial cells, smooth muscle adventitial stem cells (each can activated); (3) infiltration various leukocyte types; (4) increased critical growth factors mediators; (5) marked ECM, remodels from homeostatic, prodifferentiation environment matrices instead promote tissue reparative responses. This latter presents previously hidden matricryptic sites bind integrins signal infiltrating leukocytes (in coordination other mediators) proliferate, invade, secrete ECM-degrading proteinases, deposit injury-induced (predisposing vessel fibrosis). In contrast, similar capillaries undergo regression responses (rarefaction). summary, we have described molecular events controlling major diseases well differential arteries versus key mediators inducing injury.

Язык: Английский

Процитировано

45

Fibrosis of the diabetic heart: Clinical significance, molecular mechanisms, and therapeutic opportunities DOI Creative Commons
Izabela Tuleta, Nikolaos G. Frangogiannis

Advanced Drug Delivery Reviews, Год журнала: 2021, Номер 176, С. 113904 - 113904

Опубликована: Июль 29, 2021

Язык: Английский

Процитировано

89

Common mechanisms underlying diabetic vascular complications: focus on the interaction of metabolic disorders, immuno-inflammation, and endothelial dysfunction DOI Creative Commons
Chongxiang Xue, Keyu Chen, Zezheng Gao

и другие.

Cell Communication and Signaling, Год журнала: 2023, Номер 21(1)

Опубликована: Окт. 30, 2023

Abstract Diabetic vascular complications (DVCs), including macro- and micro- angiopathy, account for a high percentage of mortality in patients with diabetes mellitus (DM). Endothelial dysfunction is the initial role step pathogenesis DVCs. Hyperglycemia lipid metabolism disorders contribute to endothelial via direct injury products, crosstalk between immunity inflammation, as well related interaction network. Although physiological phenotypic differences support their specified changes different targeted organs, there are still several common mechanisms underlying Also, inhibitors these may decrease incidence DVCs effectively. Thus, this review provide new insights into possible measures secondary prevention DM. And we discussed current limitations those present preventive research.

Язык: Английский

Процитировано

42

NPRC deletion attenuates cardiac fibrosis in diabetic mice by activating PKA/PKG and inhibiting TGF-β1/Smad pathways DOI Creative Commons
Linlin Meng, Yue Lu, Xinlu Wang

и другие.

Science Advances, Год журнала: 2023, Номер 9(31)

Опубликована: Авг. 2, 2023

Cardiac fibrosis plays a key role in the progression of diabetic cardiomyopathy (DCM). Previous studies demonstrated cardioprotective effects natriuretic peptides. However, peptide receptor C (NPRC) on cardiac DCM remains unknown. Here, we observed that myocardial NPRC expression was increased mice and patients with DCM.

Язык: Английский

Процитировано

37

Vascular organoids: unveiling advantages, applications, challenges, and disease modelling strategies DOI Creative Commons
Hojjat Naderi‐Meshkin, Victoria A. Cornelius, Magdalini Eleftheriadou

и другие.

Stem Cell Research & Therapy, Год журнала: 2023, Номер 14(1)

Опубликована: Окт. 10, 2023

Abstract Understanding mechanisms and manifestations of cardiovascular risk factors, including diabetes, on vascular cells such as endothelial cells, pericytes, smooth muscle remains elusive partly due to the lack appropriate disease models. Therefore, here we explore different aspects for development advanced 3D in vitro models that recapitulate human blood vessel complications using patient-derived induced pluripotent stem which retain epigenetic, transcriptomic, metabolic memory their patient-of-origin. In this review, highlight superiority organoids over conventional 2D cell culture systems research. We outline key benefits both health contexts discuss current challenges associated with organoid technology, providing potential solutions. Furthermore, diverse applications emphasize importance incorporating all relevant cellular components a model accurately pathophysiology. As specific example, present comprehensive overview diabetic vasculopathy, demonstrating how interplay types is critical successful modelling complex processes vitro. Finally, propose strategy creating an organ-specific vasculopathy model, serving valuable template other diseases by disease-specific stressors organotypic modifications. Graphical abstract

Язык: Английский

Процитировано

34